Test Price
2,800 AED✅ Home Collection Available
COMP Gene Pseudoachondroplasia Genetic Test in UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO-accredited NGS processing, ensuring reliable detection of COMP gene mutations.
- Premium Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM across all UAE emirates.
- Clinical Guidance: Telephonic post-test consultation with our clinical genetics team to interpret results within a clinical context.
- Insurance Support: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This advanced genetic test utilizes Next‑Generation Sequencing to interrogate the entire COMP gene, diagnosing pseudoachondroplasia with high precision and guiding clinical management. The assay detects single nucleotide variants, insertions, deletions, and copy number variations across all exons, splice sites, and regulatory regions.
| Feature | Our NGS Panel | Alternative Single‑Gene Testing |
|---|---|---|
| Method | Next‑Generation Sequencing (NGS) – full gene coverage | Sanger sequencing or limited exon analysis |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Diagnostic Sensitivity | 99.9% (including deep intronic and copy number variants) | ~95% (misses large deletions and duplications) |
| Coverage | Complete COMP gene (all exons, splice sites, regulatory regions) | Selected hot‑spot exons only |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403) shares: “As a clinical geneticist, I emphasize that this targeted gene analysis provides definitive molecular confirmation of pseudoachondroplasia but must be interpreted alongside comprehensive clinical and radiographic findings. A negative result does not exclude other skeletal dysplasias, and a positive result requires correlation with the patient’s phenotype. Pre‑test genetic counseling is mandatory to ensure informed consent and appropriate test selection.”
Advisory on Genetic Testing
This test is intended for diagnostic confirmation of pseudoachondroplasia in individuals with suggestive clinical features. Results should not be used as the sole basis for treatment decisions. A formal genetics consultation is recommended for all patients prior to testing. Patients are advised to maintain their current medication regimen unless explicitly directed otherwise by their treating physician.
Exclusion Criteria & Emergency Red Flags
- Inability to provide informed consent for genetic testing (patient or legal guardian).
- Active severe bleeding disorder that precludes safe venipuncture.
- Minors without accompanying legal guardian in accordance with UAE Federal Law No. 2 of 2019.
- Seek immediate medical attention if you experience:
- Sudden worsening of joint pain or inability to bear weight.
- New‑onset numbness, tingling, or weakness in the limbs.
- Respiratory distress or chest pain.
Patient FAQ & Clinical Guidance
1. What is the accuracy of the COMP gene test?
Our NGS‑based COMP gene analysis delivers 99.9% diagnostic sensitivity, detecting over 95% of known pathogenic variants including deletions, duplications, and deep intronic mutations.
2. Is home sample collection available in Dubai and Abu Dhabi?
Yes, our ISO‑certified phlebotomy team provides VIP mobile phlebotomy with temperature‑controlled cold‑chain transport across all UAE emirates daily from 8 AM to 11 PM, with no additional travel charges.
3. Do I need a doctor’s referral for this test?
A clinical referral and mandatory pre‑test genetic counseling session are required to ensure appropriate indication and informed consent, in compliance with UAE regulatory standards.
4. How long does it take to receive results?
The turnaround time is 3–4 weeks from sample receipt. This duration allows for comprehensive NGS data analysis, variant interpretation, and clinical correlation.
5. Will my insurance cover this genetic test?
Coverage varies by insurer and policy. Direct billing verification is available via WhatsApp at +971 54 548 8731. Please contact our billing team for a personalized assessment.
UAE Regulatory & Data Privacy Adherence
All genetic analyses are performed in strict compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent, data encryption, and access control protocols are enforced at every stage. Clinical safety and patient consent procedures adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability. DNA Labs UAE holds DHA Facility License Number 1143 and maintains ISO 9001:2015 certification for quality management.
Clinical & Logistical Metadata
| Test Name | COMP Gene Pseudoachondroplasia Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | Next‑Generation Sequencing (NGS) |
| ICD-10-CM Code | Q77.3 |
| LOINC Code | 21635-2 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians